Debanjan Ray News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Debanjan ray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Debanjan Ray Today - Breaking & Trending Today
Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
BOSTON & WEST HAVEN, Conn. (BUSINESS WIRE) Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv. ....
Synthekine, Merck partner to develop new cytokine-based therapies pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
Stanford spinout Synthekine raises $107.5M on promise of new way to attack cancer, autoimmune diseases bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
MENLO PARK, Calif. (BUSINESS WIRE) Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Pablo Cagnoni, M.D., to its board of directors. Dr. Cagnoni brings to Synthekine extensive leadership experience in the biotech industry and a successful track record of oncology drug development. The company also announced the formation of its scientific advisory board to help guide the company’s extensive cytokine engineering efforts. “Synthekine has made significant advances in 2020, with our first programs on track for IND filings in 2021, and I am delighted to have Pablo join our board of directors and bring his considerable insights in developing breakthrough oncology products to support our continued progress,” said Debanjan Ray, CEO of Synthekine. “At the same time, our distinguished scientific advisory board will provide guidance as we apply our multiple cytokine engineering effo ....